MedTrace Logo

Hearing Instruments in Alzheimer's Disease

NCT02294513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2017-04-11

No results posted yet for this study

Summary

There is a strong connection between hearing loss and cognitive impairment, particularly dementia, in old age. Worldwide, dementia affects approximately 5% of persons over the age of 65 years. Hearing loss is even more prevalent in old age, affecting an estimated one third of persons over the age of 65 years. Thus, there is likely a large degree of overlap between the impairments. Indeed, this overlap may influence older adults' everyday functioning, communication, social engagement and quality of life, as well as influencing the well-being of their family caregivers. This project will examine whether patients with hearing loss and Alzheimer's disease, the most common form of dementia, derive benefit the from hearing aids prescribed and fit to them following current best practice procedures in a geriatric audiology clinic. For the first time, a formal evaluation of the potential benefits of hearing aids for the patients' family caregivers will also be conducted.

Conditions

Interventions

DEVICE

Standard audiologic rehabilitation (incl. HI)

The intervention consists of standard audiologic rehabilitation in which participants are fit with at least one hearing instrument (HI).

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER

  • Baycrest Centre for Geriatric Care

    collaborator OTHER

  • Phonak AG, Switzerland

    lead INDUSTRY

Principal Investigators

  • Kathleen Pichora-Fuller, Prof. · University of Toronto

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02294513 on ClinicalTrials.gov